Right: Cytodyne wants it because it has been in 9 clinical trials, works, and works better for HIV than other treatements. Vyera Pharmaceuticals - real company with over 100 employees per zoominfo wants it to work because they developed it.
Massive potential and a tiny TINY float. What's not to like at this point?
My philosophy is to just be honest and balanced, and let the market decide if it agrees or not.
Market Data 
Markets 
AI
